Related Experiment Video
Updated: Jan 23, 2026

Isolation of Mouse Coronary Endothelial Cells
Published on: July 3, 2016
Induction of decay accelerating factor and membrane cofactor protein by resveratrol attenuates complement deposition
Maria G Detsika1, Eleni D Myrtsi2, Sofia D Koulocheri2
1First Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Research Center of Intensive Care and Emergency Thoracic Medicine, Evangelismos Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Insights
Resveratrol, found in red wine, protects against cardiovascular disease by boosting heme-oxygenase (HO)-1. This increases complement regulatory proteins, reducing harmful C3b deposition in blood vessels.
Area of Science:
- Cardiovascular Disease Research
- Immunology and Complement System
- Molecular Biology and Cell Signaling
Background:
- Complement activation is implicated in cardiovascular disease (CVD) progression and treatment.
- Resveratrol, a compound in red wine, shows protective effects against CVD, but its mechanisms are unclear.
- Understanding resveratrol's molecular targets is crucial for developing targeted CVD therapies.
Purpose of the Study:
- To investigate if resveratrol's CVD protective effects are mediated by upregulating complement regulatory proteins via heme-oxygenase (HO)-1 induction.
- To assess resveratrol's impact on HO-1, membrane cofactor protein (MCP, CD46), decay-accelerating factor (DAF, CD55), and CD59 expression in human coronary artery endothelial cells (HCAECs).
- To determine the role of HO-1 and DAF in resveratrol's ability to reduce complement-mediated C3b deposition.
Main Methods:
- HCAECs were treated with resveratrol at concentrations found in red wine.
- HO-1, MCP (CD46), DAF (CD55), and CD59 expression levels were measured.
- HO-1 was silenced using siRNAs, and DAF function was blocked with an antibody.
- C3b deposition was quantified after complement activation using normal human or rat serum.
Main Results:
- Resveratrol significantly increased HO-1, MCP (CD46), and DAF (CD55) expression in HCAECs, with no effect on CD59.
- Silencing HO-1 abolished resveratrol-induced MCP and DAF expression.
- Resveratrol-induced MCP and DAF reduced C3b deposition.
- Blocking DAF or silencing HO-1 increased C3b deposition in the presence of complement.
Conclusions:
- Resveratrol protects against cardiovascular disease through a novel mechanism involving HO-1 induction.
- HO-1 upregulates complement regulatory proteins DAF and MCP, which reduce harmful C3b deposition.
- This study highlights the critical role of the HO-1/DAF pathway in mediating resveratrol's cardioprotective effects.
Abstract:
The involvement of complement activation in various forms of cardiovascular disease renders it an important factor for disease progression and therapeutic intervention. The protective effect of resveratrol against cardiovascular disease via moderate red wine consumption has been established but the exact mechanisms are still under investigation. The current study utilised human coronary artery endothelial cells (HCAECs) in order to assess the extent to which the protective effect of resveratrol, at concentrations present in red wine, can be attributed to the upregulation of complement regulatory proteins through heme-oxygenase (HO)-1 induction. Resveratrol at concentrations as low as 0.001 μΜ increased HO-1 expression as well as membrane cofactor protein (MCP, CD46) and decay-accelerating factor (DAF, CD55) expression with no-effect on CD59. Silencing of HO-1 expression by HO-1 siRNAs abrogated both DAF and MCP protein expression with no effect on CD59. Resveratrol-mediated induction of DAF and MCP reduced C3b deposition following incubation of HCAECs with 10% normal human serum or normal rat serum as a source of complement. Incubation of HCAECs, with either a DAF blocking antibody or following transfection with HO-1 siRNAs, in the presence of 10% normal rat serum increased C3b deposition, indicating that both DAF and HO-1 are required for C3b reduction. These observations support a novel mechanism for the protective effect of resveratrol against cardiovascular disease and confirm the important role of HO-1 in the regulation of the complement cascade.
Related Concept Videos
Cofactors and Coenzymes
Coronary Artery Disease I: Introduction
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Coronary Artery Disease II: Pathophysiology
Introduction to Membrane Proteins
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...

